BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34668631)

  • 1. Targeting of EIF4EBP1 by miR-99a-3p affects the functions of B lymphocytes via autophagy and aggravates SLE disease progression.
    Yang M; Yang B; Deng D
    J Cell Mol Med; 2021 Nov; 25(21):10291-10305. PubMed ID: 34668631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced miR-99a-3p levels in systemic lupus erythematosus may promote B cell proliferation via NCAPG and the PI3K/AKT signaling pathway.
    Zhu QH; Zhou YL; Yang M; Yang BB; Cao WT; Yuan LM; Deng DQ
    Lupus; 2024 Apr; 33(4):365-374. PubMed ID: 38320572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-590-3p inhibits T helper 17 cells and ameliorates inflammation in lupus mice.
    Huang J; Xu X; Wang X; Yang J; Xue M; Yang Y; Zhang R; Yang X; Yang J
    Immunology; 2022 Feb; 165(2):260-273. PubMed ID: 34775599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonizing miR-7 suppresses B cell hyperresponsiveness and inhibits lupus development.
    Wang M; Chen H; Qiu J; Yang HX; Zhang CY; Fei YY; Zhao LD; Zhou JX; Wang L; Wu QJ; Zhou YZ; Zhang W; Zhang FC; Zhang X; Lipsky PE
    J Autoimmun; 2020 May; 109():102440. PubMed ID: 32201226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of microRNA-448 suppresses CD4
    Zhang J; Guo Y; Sun Y; Chang L; Wang X
    Biochem Biophys Res Commun; 2022 Mar; 596():88-96. PubMed ID: 35121374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of miR-200a-3p, Targeting CtBP2 Complex, Is Involved in the Hypoproduction of IL-2 in Systemic Lupus Erythematosus-Derived T Cells.
    Katsuyama E; Yan M; Watanabe KS; Narazaki M; Matsushima S; Yamamura Y; Hiramatsu S; Ohashi K; Watanabe H; Katsuyama T; Zeggar S; Yoshida N; Moulton VR; Tsokos GC; Sada KE; Wada J
    J Immunol; 2017 Jun; 198(11):4268-4276. PubMed ID: 28438897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus.
    Ding S; Liang Y; Zhao M; Liang G; Long H; Zhao S; Wang Y; Yin H; Zhang P; Zhang Q; Lu Q
    Arthritis Rheum; 2012 Sep; 64(9):2953-63. PubMed ID: 22549634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulated miR‑29a promotes B cell overactivation by upregulating Crk‑like protein in systemic lupus erythematosus.
    Shi X; Ye L; Xu S; Guo G; Zuo Z; Ye M; Zhu L; Li B; Xue X; Lin Q; Ding X
    Mol Med Rep; 2020 Aug; 22(2):841-849. PubMed ID: 32467986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircIBTK inhibits DNA demethylation and activation of AKT signaling pathway via miR-29b in peripheral blood mononuclear cells in systemic lupus erythematosus.
    Wang X; Zhang C; Wu Z; Chen Y; Shi W
    Arthritis Res Ther; 2018 Jun; 20(1):118. PubMed ID: 29884225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased miR-4512 Levels in Monocytes and Macrophages of Individuals With Systemic Lupus Erythematosus Contribute to Innate Immune Activation and Neutrsophil NETosis by Targeting TLR4 and CXCL2.
    Yang B; Huang X; Xu S; Li L; Wu W; Dai Y; Ge MX; Yuan L; Cao W; Yang M; Wu Y; Deng D
    Front Immunol; 2021; 12():756825. PubMed ID: 34721432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-153-3p induces immune dysregulation by inhibiting PELI1 expression in umbilical cord-derived mesenchymal stem cells in patients with systemic lupus erythematosus.
    Li D; Li X; Duan M; Dou Y; Feng Y; Nan N; Zhang W
    Autoimmunity; 2020 Jun; 53(4):201-209. PubMed ID: 32321315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of microRNA-101-3p participates in systemic lupus erythematosus progression via negatively regulating HDAC9.
    Sun H; Guo F; Xu L
    J Cell Biochem; 2020 Oct; 121(10):4310-4320. PubMed ID: 31904179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excessive miR-152-3p Results in Increased BAFF Expression in SLE B-Cells by Inhibiting the KLF5 Expression.
    Luo S; Ding S; Liao J; Zhang P; Liu Y; Zhao M; Lu Q
    Front Immunol; 2019; 10():1127. PubMed ID: 31178864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jieduquyuziyin prescription enhances CD11a and CD70 DNA methylation of CD4
    Huang S; Peng J; Gan Y; Chen L; Zhu Z; Tian F; Ji L; Fan Y; Zhou C; Bao J
    J Ethnopharmacol; 2023 Dec; 317():116776. PubMed ID: 37343653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Toll-like receptor-mediated inflammatory response by microRNA-152-3p-mediated demethylation of MyD88 in systemic lupus erythematosus.
    Tao B; Xiang W; Li X; He C; Chen L; Xia X; Peng T; Peng L; Yang X; Zhong C
    Inflamm Res; 2021 Mar; 70(3):285-296. PubMed ID: 33507312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-98 Modulates Cytokine Production from Human PBMCs in Systemic Lupus Erythematosus by Targeting IL-6 mRNA.
    Yuan S; Tang C; Chen D; Li F; Huang M; Ye J; He Z; Li W; Chen Y; Lin X; Wang X; Cai X
    J Immunol Res; 2019; 2019():9827574. PubMed ID: 31886314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-18a-3p Encourages Apoptosis of Chondrocyte in Osteoarthritis via HOXA1 Pathway.
    Ding B; Xu S; Sun X; Gao J; Nie W; Xu H
    Curr Mol Pharmacol; 2020; 13(4):328-341. PubMed ID: 32013856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of MiR-98 and Its Underlying Mechanisms in Systemic Lupus Erythematosus.
    Xie L; Xu J
    J Rheumatol; 2018 Oct; 45(10):1397-1405. PubMed ID: 29907673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjögren's syndrome.
    Chen JQ; Papp G; Póliska S; Szabó K; Tarr T; Bálint BL; Szodoray P; Zeher M
    PLoS One; 2017; 12(3):e0174585. PubMed ID: 28339495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of FcγRIIB regulates downstream protein phosphorylation and suppresses B cell activation to ameliorate systemic lupus erythematosus.
    Sheng L; Cao X; Chi S; Wu J; Xing H; Liu H; Yang Z
    Int J Mol Med; 2020 Oct; 46(4):1409-1422. PubMed ID: 32945349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.